Dr.med. Jan Fehr
Ability to Work and Employment Rates in Human Immunodeficiency Virus (HIV)-1-Infected Individuals Receiving Combination Antiretroviral Therapy: The Swiss HIV Cohort Study
Elzi L, Furrer H, Bernasconi E, Schmid P, Calmy A, Cavassini M, Fehr J, Patzen A, Conen A, Battegay M. Ability to Work and Employment Rates in Human Immunodeficiency Virus (HIV)-1-Infected Individuals Receiving Combination Antiretroviral Therapy: The Swiss HIV Cohort Study. Open Forum Infect Dis 2016; 3:ofw022.
Feb 1, 2016Ability to Work and Employment Rates in Human Immunodeficiency Virus (HIV)-1-Infected Individuals Receiving Combination Antiretroviral Therapy: The Swiss HIV Cohort Study
Feb 1, 2016Open Forum Infect Dis 2016; 3:ofw022
Elzi Luigia, Furrer Hansjakob, Bernasconi Enos, Schmid Patrick, Calmy Alexandra, Cavassini Matthias, Fehr Jan, Patzen Annalea, Conen Anna, Battegay Manuel
Switch to etravirine for HIV-positive patients receiving statin treatment: a prospective study
Ciaffi L, Calmy A, Montecucco F, Hirschel B, Schmid P, Stoeckle M, Fehr J, Wandeler G, Hill A, Spycher Elbes R, Delhumeau C, Genné D, Cavassini M, Swiss HIV Cohort Study. Switch to etravirine for HIV-positive patients receiving statin treatment: a prospective study. Eur J Clin Invest 2015
May 20, 2015Switch to etravirine for HIV-positive patients receiving statin treatment: a prospective study
May 20, 2015Eur J Clin Invest 2015
Ciaffi Laura, Calmy Alexandra, Montecucco Fabrizio, Hirschel Bernard, Schmid Patrick, Stoeckle Marcel, Fehr Jan, Wandeler Gilles, Hill Andrew, Spycher Elbes Rachel, Delhumeau Cécile, Genné Daniel, Cavassini Matthias, Swiss HIV Cohort Study
Syphilis: Diagnostik und Behandlung
Itin P, Schmid P, Bernasconi E, Harry D, Boffi El Amari E, Herold M, Klimkait T, Kahlert C, Furrer H, Lautenschlager S, Calmy A, Cavassini M, Oertle D, Low N, Bosshard P, Toutous-Trellu L, Schmidt A, Vernazza P, Tarr P, Stoeckle M, Wymann M, Ciardo D, Class J, Scheidegger C, Fehr J. Syphilis: Diagnostik und Behandlung - Aktualisierte Empfehlungen der Eidgenössischen Kommission für Sexuelle Gesundheit. Schweizerisches Medizin-Forum 2015; 15:459-465.
May 6, 2015Syphilis: Diagnostik und Behandlung
May 6, 2015Schweizerisches Medizin-Forum 2015; 15:459-465
Itin Peter, Schmid Patrick, Bernasconi Enos, Harry David, Boffi El Amari Emnanuelle, Herold Markus, Klimkait Thomas, Kahlert Christian, Furrer Hansjakob, Lautenschlager Stephan, Calmy Alexandra, Cavassini Matthias, Oertle Daniel, Low Nicola, Bosshard Philipp P., Toutous-Trellu Laurence, Schmidt Axel J., Vernazza Pietro, Tarr Philip, Stoeckle Marcel, Wymann Monica, Ciardo Diana, Class Johanna, Scheidegger Claude, Fehr Jan
Incident Hepatitis C Virus Infections in the Swiss HIV Cohort Study: Changes in Treatment Uptake and Outcomes Between 1991 and 2013
Yerly S, Metzner K, Martinez de Tejada B, Martinetti G, Ledergerber B, Kovari H, Kouyos R, Klimkait T, Keiser O, Kaiser L, Kahlert C, Hösli I, Hoffmann M, Hirsch H, Hasse B, Müller N, Nadal D, Weber R, Vernazza P, Trkola A, Telenti A, Tarr P, Speck R, Schüpbach J, Schöni-Affolter F, Rudin C, Rickenbach M, Regenass S, Rauch A, Pantaleo G, Nicca D, Haerry D, Günthard H, Gorgievski M, Rauch A, Furrer H, Salazar-Vizcaya L, Keiser O, Bernasconi E, Schmid P, Stöckle M, Cavassini M, Ambrosioni J, Fehr J, Metzner K, Rohrbach J, Jaquier M, Schlauri M, Swiss HIV Cohort Study, Aubert V, Fux C, Furrer H, Fellay J, Fehr J, Elzi L, Egger M, Dollenmaier G, Cavassini M, Calmy A, Burton-Jeangros C, Bucher H, Böni J, Bernasconi E, Battegay M, Wandeler G. Incident Hepatitis C Virus Infections in the Swiss HIV Cohort Study: Changes in Treatment Uptake and Outcomes Between 1991 and 2013. Open Forum Infect Dis 2015; 2:ofv026.
Mar 25, 2015Incident Hepatitis C Virus Infections in the Swiss HIV Cohort Study: Changes in Treatment Uptake and Outcomes Between 1991 and 2013
Mar 25, 2015Open Forum Infect Dis 2015; 2:ofv026
Yerly S, Metzner K, Martinez de Tejada B, Martinetti G, Ledergerber B, Kovari H, Kouyos R, Klimkait T, Keiser O, Kaiser L, Kahlert Christian, Hösli I, Hoffmann M, Hirsch H H, Hasse B, Müller N, Nadal D, Weber R, Vernazza Pietro, Trkola A, Telenti A, Tarr P, Speck R, Schüpbach J, Schöni-Affolter F, Rudin C, Rickenbach M, Regenass S, Rauch A, Pantaleo G, Nicca D, Haerry D, Günthard H, Gorgievski M, Rauch Andri, Furrer Hansjakob, Salazar-Vizcaya Luisa, Keiser Olivia, Bernasconi Enos, Schmid Patrick, Stöckle Marcel, Cavassini Matthias, Ambrosioni Juan, Fehr Jan, Metzner Karin J, Rohrbach Janine, Jaquier Marie-Eve, Schlauri Marion, Swiss HIV Cohort Study, Aubert V, Fux C A, Furrer H, Fellay J, Fehr J, Elzi L, Egger M, Dollenmaier G, Cavassini M, Calmy A, Burton-Jeangros C, Bucher H C, Böni J, Bernasconi E, Battegay M, Wandeler Gilles
Increased mortality after a first myocardial infarction in human immunodeficiency virus-infected patients; a nested cohort study
Carballo D, Calmy A, Ledergerber B, Keller P, Erne P, Fehr J, Cusini A, Schmid P, Fasel D, Bernasconi E, Clerc O, Hirschel B, Radovanovic D, Bähler C, Carballo S, Delhumeau C, Swiss HIV Cohort Study and AMIS registry. Increased mortality after a first myocardial infarction in human immunodeficiency virus-infected patients; a nested cohort study. AIDS Res Ther 2015; 12:4.
Feb 22, 2015Increased mortality after a first myocardial infarction in human immunodeficiency virus-infected patients; a nested cohort study
Feb 22, 2015AIDS Res Ther 2015; 12:4
Carballo David, Calmy Alexandra, Ledergerber Bruno, Keller Pierre-Fréderic, Erne Paul, Fehr Jan, Cusini Alexia, Schmid Patrick, Fasel Dominique, Bernasconi Enos, Clerc Olivier, Hirschel Bernard, Radovanovic Dragona, Bähler Caroline, Carballo Sebastian, Delhumeau Cécile, Swiss HIV Cohort Study and AMIS registry
"Fighting an uphill battle": experience with the HCV triple therapy: a qualitative thematic analysis
Rasi M, Künzler-Heule P, Schmid P, Semela D, Bruggmann P, Fehr J, Saxer S, Nicca D. "Fighting an uphill battle": experience with the HCV triple therapy: a qualitative thematic analysis. BMC Infect Dis 2014; 14:507.
Sep 18, 2014"Fighting an uphill battle": experience with the HCV triple therapy: a qualitative thematic analysis
Sep 18, 2014BMC Infect Dis 2014; 14:507
Rasi Manuela, Künzler-Heule Patrizia, Schmid Patrick, Semela David, Bruggmann Philip, Fehr Jan, Saxer Susi, Nicca Dunja
Virologic and immunologic responses in treatment-naive patients to ritonavir-boosted atazanavir or efavirenz with a common backbone
Wang Q, Battegay M, Bucher H, Fehr J, Furrer H, Cavassini M, Calmy A, Vernazza P, Bernasconi E, Young J, Swiss HIV Cohort Study. Virologic and immunologic responses in treatment-naive patients to ritonavir-boosted atazanavir or efavirenz with a common backbone. HIV Clin Trials 2014; 15:92-103.
May 1, 2014Virologic and immunologic responses in treatment-naive patients to ritonavir-boosted atazanavir or efavirenz with a common backbone
May 1, 2014HIV Clin Trials 2014; 15:92-103
Wang Qing, Battegay Manuel, Bucher Heiner C, Fehr Jan, Furrer Hansjakob, Cavassini Matthias, Calmy Alexandra, Vernazza Pietro, Bernasconi Enos, Young Jim, Swiss HIV Cohort Study
Co-trimoxazole prophylaxis is associated with reduced risk of incident tuberculosis in participants in the Swiss HIV Cohort Study
Hasse B, Ledergerber B, Weber R, Di Benedetto C, Fellay J, Calmy A, Battegay M, Hoffmann M, Furrer H, Fehr J, Walker A, Swiss HIV Cohort Study. Co-trimoxazole prophylaxis is associated with reduced risk of incident tuberculosis in participants in the Swiss HIV Cohort Study. Antimicrob Agents Chemother 2014; 58:2363-8.
Feb 10, 2014Co-trimoxazole prophylaxis is associated with reduced risk of incident tuberculosis in participants in the Swiss HIV Cohort Study
Feb 10, 2014Antimicrob Agents Chemother 2014; 58:2363-8
Hasse Barbara, Ledergerber Bruno, Weber Rainer, Di Benedetto Caroline, Fellay Jacques, Calmy Alexandra, Battegay Manuel, Hoffmann Matthias, Furrer Hansjakob, Fehr Jan, Walker A Sarah, Swiss HIV Cohort Study
Association of alcohol consumption and HIV surrogate markers in participants of the swiss HIV cohort study
Conen A, Battegay M, Bucher H, Weber R, Vernazza P, Bernasconi E, Calmy A, Orasch C, Thurnheer M, Fux C, Glass T, Wang Q, Fehr J. Association of alcohol consumption and HIV surrogate markers in participants of the swiss HIV cohort study. J Acquir Immune Defic Syndr 2013; 64:472-8.
Dec 15, 2013Association of alcohol consumption and HIV surrogate markers in participants of the swiss HIV cohort study
Dec 15, 2013J Acquir Immune Defic Syndr 2013; 64:472-8
Conen Anna, Battegay Manuel, Bucher Heiner C, Weber Rainer, Vernazza Pietro, Bernasconi Enos, Calmy Alexandra, Orasch Christina, Thurnheer Maria C, Fux Christoph A, Glass Tracy R, Wang Qing, Fehr Jan
Missed opportunities among HIV-positive women to control viral replication during pregnancy and to have a vaginal delivery
Aebi-Popp K, European Collaborative Study in EuroCoord, Thorne C, Hoesli I, Rickenbach M, Scheibner K, Grawe C, Fehr J, Bertisch B, Martinez de Tejada B, Rudin C, Glass T, Mulcahy F, Swiss Mother & Child HIV Cohort Study. Missed opportunities among HIV-positive women to control viral replication during pregnancy and to have a vaginal delivery. J Acquir Immune Defic Syndr 2013; 64:58-65.
Sep 1, 2013Missed opportunities among HIV-positive women to control viral replication during pregnancy and to have a vaginal delivery
Sep 1, 2013J Acquir Immune Defic Syndr 2013; 64:58-65
Aebi-Popp Karoline, European Collaborative Study in EuroCoord, Thorne Claire, Hoesli Irene, Rickenbach Martin, Scheibner Kathrin, Grawe Claudia, Fehr Jan, Bertisch Barbara, Martinez de Tejada Begoña, Rudin Christoph, Glass Tracy R, Mulcahy Fiona, Swiss Mother & Child HIV Cohort Study
HIV Infection Disrupts the Sympatric Host-Pathogen Relationship in Human Tuberculosis
Fenner L, Cavassini M, Calmy A, Dolina M, Frei R, Janssens J, Borrell S, Stucki D, Schrenzel J, Böttger E, Gagneux S, Bernasconi E, Hoffmann M, Egger M, Bodmer T, Furrer H, Ballif M, Battegay M, Helbling P, Fehr J, Gsponer T, Rieder H, Zwahlen M, Swiss HIV Cohort and Molecular Epidemiology of Tuberculosis Study Groups. HIV Infection Disrupts the Sympatric Host-Pathogen Relationship in Human Tuberculosis. PLoS Genet 2013; 9:e1003318.
Mar 7, 2013HIV Infection Disrupts the Sympatric Host-Pathogen Relationship in Human Tuberculosis
Mar 7, 2013PLoS Genet 2013; 9:e1003318
Fenner Lukas, Cavassini Matthias, Calmy Alexandra, Dolina Marisa, Frei Reno, Janssens Jean-Paul, Borrell Sonia, Stucki David, Schrenzel Jacques, Böttger Erik C, Gagneux Sebastien, Bernasconi Enos, Hoffmann Matthias, Egger Matthias, Bodmer Thomas, Furrer Hansjakob, Ballif Marie, Battegay Manuel, Helbling Peter, Fehr Jan, Gsponer Thomas, Rieder Hans L, Zwahlen Marcel, Swiss HIV Cohort and Molecular Epidemiology of Tuberculosis Study Groups
Impact of recommendation updates in well-controlled patients on nonrecommended antiretroviral therapies: the Swiss HIV cohort study
Boillat-Blanco N, Wandeler G, Fehr J, Daou S, Elzi L, Adami M, Strahm C, Osih R, Taffé P, Darling K, Cavassini M. Impact of recommendation updates in well-controlled patients on nonrecommended antiretroviral therapies: the Swiss HIV cohort study. J Acquir Immune Defic Syndr 2013; 62:180-9.
Feb 1, 2013Impact of recommendation updates in well-controlled patients on nonrecommended antiretroviral therapies: the Swiss HIV cohort study
Feb 1, 2013J Acquir Immune Defic Syndr 2013; 62:180-9
Boillat-Blanco Noémie, Wandeler Gilles, Fehr Jan, Daou Samira, Elzi Luigia, Adami Maddalena, Strahm Carol, Osih Regina, Taffé Patrick, Darling Katharine E A, Cavassini Matthias
Tuberculosis in HIV-negative and HIV-infected patients in a low-incidence country: clinical characteristics and treatment outcomes
Fenner L, Egger M, Helbling P, Böttger E, Bodmer T, Schrenzel J, Bernasconi E, Hoffmann M, Cavassini M, Fehr J, Janssens J, Gagneux S, Swiss HIV Cohort and Molecular Epidemiology of Tuberculosis Study Groups. Tuberculosis in HIV-negative and HIV-infected patients in a low-incidence country: clinical characteristics and treatment outcomes. PloS one 2012; 7:e34186.
Mar 30, 2012Tuberculosis in HIV-negative and HIV-infected patients in a low-incidence country: clinical characteristics and treatment outcomes
Mar 30, 2012PloS one 2012; 7:e34186
Fenner Lukas, Egger Matthias, Helbling Peter, Böttger Erik C, Bodmer Thomas, Schrenzel Jacques, Bernasconi Enos, Hoffmann Matthias, Cavassini Matthias, Fehr Jan, Janssens Jean-Paul, Gagneux Sebastien, Swiss HIV Cohort and Molecular Epidemiology of Tuberculosis Study Groups
Improved sensitivity of an interferon-gamma release assay (T-SPOT.TB) in combination with tuberculin skin test for the diagnosis of latent tuberculosis in the presence of HIV co-Infection
Elzi L, Bassetti S, Bernasconi E, Hoffmann M, Hirschel B, Cavassini M, Fehr J, Furrer H, Steffen I, Battegay M. Improved sensitivity of an interferon-gamma release assay (T-SPOT.TB) in combination with tuberculin skin test for the diagnosis of latent tuberculosis in the presence of HIV co-Infection. BMC Infect Dis 2011; 11:319.
Nov 15, 2011Improved sensitivity of an interferon-gamma release assay (T-SPOT.TB) in combination with tuberculin skin test for the diagnosis of latent tuberculosis in the presence of HIV co-Infection
Nov 15, 2011BMC Infect Dis 2011; 11:319
Elzi Luigia, Bassetti Stefano, Bernasconi Enos, Hoffmann Matthias, Hirschel Bernard, Cavassini Matthias, Fehr Jan, Furrer Hansjakob, Steffen Ingrid, Battegay Manuel
Replicative phenotyping adds value to genotypic resistance testing in heavily pre-treated HIV-infected individuals - the Swiss HIV Cohort Study
Fehr J, Hirschel B, Vernazza P, Martinetti G, Bernasconi E, Günthard H, Battegay M, Bucher H, Klimkait T, Fux C, Cavassini M, Glass T, Louvel S, Hamy F, Hirsch H, von Wyl V, Böni J, Yerly S, Bürgisser P, Hiv Cohort Study A. Replicative phenotyping adds value to genotypic resistance testing in heavily pre-treated HIV-infected individuals - the Swiss HIV Cohort Study. J Transl Med 2011; 9:14.
Jan 21, 2011Replicative phenotyping adds value to genotypic resistance testing in heavily pre-treated HIV-infected individuals - the Swiss HIV Cohort Study
Jan 21, 2011J Transl Med 2011; 9:14
Fehr Jan, Hirschel Bernard, Vernazza Pietro, Martinetti Gladys, Bernasconi Enos, Günthard Huldrych F, Battegay Manuel, Bucher Heiner C, Klimkait Thomas, Fux Christoph A, Cavassini Matthias, Glass Tracy R, Louvel Severine, Hamy Francois, Hirsch Hans H, von Wyl Viktor, Böni Jürg, Yerly Sabine, Bürgisser Philippe, Hiv Cohort Study And The Swiss
High prevalence of anorectal chlamydial infection in HIV-infected men who have sex with men in Switzerland
Dang T, Tarr P, Odorico M, Cavassini M, Boffi El Amari E, Schmid P, Fehr J, Evison J, Kovari H, Flepp M, Jaton-Ogay K, Greub G. High prevalence of anorectal chlamydial infection in HIV-infected men who have sex with men in Switzerland. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2009; 49:1532-5.
Nov 15, 2009High prevalence of anorectal chlamydial infection in HIV-infected men who have sex with men in Switzerland
Nov 15, 2009Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2009; 49:1532-5
Dang Thanh, Tarr Philip E, Odorico Massimo, Cavassini Matthias, Boffi El Amari Emmanuelle, Schmid Patrick, Fehr Jan, Evison John-Marc, Kovari Helen, Flepp Markus, Jaton-Ogay Katia, Greub Gilbert
Self-reported alcohol consumption and its association with adherence and outcome of antiretroviral therapy in the Swiss HIV Cohort Study
Conen A, Battegay M, Bucher H, Bernasconi E, Cavassini M, Hirschel B, Vernazza P, Weber R, Furrer H, Glass T, Fehr J, Swiss HIV Cohort Study. Self-reported alcohol consumption and its association with adherence and outcome of antiretroviral therapy in the Swiss HIV Cohort Study. Antiviral therapy 2009; 14:349-57.
Jan 1, 2009Self-reported alcohol consumption and its association with adherence and outcome of antiretroviral therapy in the Swiss HIV Cohort Study
Jan 1, 2009Antiviral therapy 2009; 14:349-57
Conen Anna, Battegay Manuel, Bucher Heiner C, Bernasconi Enos, Cavassini Matthias, Hirschel Bernard, Vernazza Pietro, Weber Rainer, Furrer Hansjakob, Glass Tracy R, Fehr Jan, Swiss HIV Cohort Study
[Ready for antiretroviral therapy? Therapy decision making experiences of persons living with HIV]
Nicca D, Fehr J, Battegay M, Spirig R. [Ready for antiretroviral therapy? Therapy decision making experiences of persons living with HIV]. Pflege 2005; 18:289-98.
Oct 1, 2005[Ready for antiretroviral therapy? Therapy decision making experiences of persons living with HIV]
Oct 1, 2005Pflege 2005; 18:289-98
Nicca Dunja, Fehr Jan, Battegay Manuel, Spirig Rebecca
Starting or changing therapy - a prospective study exploring antiretroviral decision-making
Fehr J, Spirig R, Jäger H, Vernazza P, Bregenzer T, Kiss A, Wagels T, Wolf E, Sendi P, Nicca D, Battegay M. Starting or changing therapy - a prospective study exploring antiretroviral decision-making. Infection 2005; 33:249-256.
Jan 1, 2005Starting or changing therapy - a prospective study exploring antiretroviral decision-making
Jan 1, 2005Infection 2005; 33:249-256
Fehr Jan, Spirig R, Jäger H, Vernazza Pietro, Bregenzer T, Kiss A, Wagels T, Wolf E, Sendi P, Nicca Dunja, Battegay Manuel